clodronic acid has been researched along with Sarcoma, Ewing in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boos, J; Eckervogt, V; Sonnemann, J; Truckenbrod, B; van Valen, F; Winkelmann, W | 1 |
1 other study(ies) available for clodronic acid and Sarcoma, Ewing
| Article | Year |
|---|---|
The bisphosphonate pamidronate is a potent inhibitor of Ewing's sarcoma cell growth in vitro.
Topics: Antineoplastic Agents; Cell Division; Cell Line, Tumor; Clodronic Acid; Diphosphonates; Dose-Response Relationship, Drug; Humans; Lovastatin; Pamidronate; Sarcoma, Ewing | 2003 |